Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease myocardial infarction
Symptom C0038454|stroke
Sentences 33
PubMedID- 22103669 Background: the aim of this study was to assess the impact of combined left ventricular systolic dysfunction (lvsd) and renal dysfunction (rd) on 1-year overall mortality and major adverse cardiovascular events (maces) (comprising cardiovascular death, nonfatal renfarction, target vessel revascularization, and nonfatal stroke) in patients with st-elevation myocardial infarction undergoing primary percutaneous coronary intervention (ppci).
PubMedID- 21663525 Expert opinion: clopidogrel prevents more vascular events, including stroke, in patients with a recent myocardial infarction, stroke or peripheral vascular disease than aspirin.
PubMedID- 21340221 In the patch closure group there were no perioperative deaths but there were five postoperative deaths: one due to contralateral stroke (3 months), three because of myocardial infarction (2, 14 and 18 months, respectively), and one caused by pneumonia (20 months).
PubMedID- 25962140 Moreover, dietary iron intake has been reported to be associated with increased mortality from stroke and risk of acute myocardial infarction .
PubMedID- 21737795 In the long-term follow-up (mean, 8.9+/-3.8 years) study, cox proportional hazards analysis described the association between egfr and the following end points: nonfatal/fatal ischemic stroke; composite vascular event of any stroke, myocardial infarction, revascularization/other arterial occlusive event, or vascular death; and death of any cause.
PubMedID- 26346960 The trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction 50 (tra 2 degrees p-timi 50) investigated atherothrombotic events in patients with stable atherosclerosis.
PubMedID- 23587028 The majority of deaths were due to cardiovascular disease and there was an association between fgf23 and heart failure and stroke, but not with myocardial infarction .
PubMedID- 23963333 Mortality after ischemic stroke in patients with acute myocardial infarction: predictors and trends over time in sweden.
PubMedID- 23677725 The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function.
PubMedID- 22465317 At the end of 5 years, 123 patients (6%) had incident cvd after myocardial infarction (76 with stroke and 47 with transient ischemic attack).
PubMedID- 21691731 In patients admitted for acute stroke, the clinical burden of acute myocardial infarction (ami) and acute heart failure (ahf) is unclear.
PubMedID- 21822469 Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction.
PubMedID- 20947854 Other outcomes were subsequent ischemic stroke and a composite of ischemic stroke or myocardial infarction.
PubMedID- 22064650 Background: to assess the incidence, clinical significance, and independent risk factors of stroke in patients with acute myocardial infarction (ami) treated invasively.
PubMedID- 23560221 The uk audit reports a postoperative death or stroke rate of 3%, myocardial infarction 0.8%, postoperative bleeding 4% and cranial nerve injury 4%.1 controlled trial data from 13 years earlier showed similar rates with the number harmed independent of time to surgery or severity of initial stroke.3 the nascet data, which allow the risk of surgery to be isolated from the background risk, show a net increase in surgical risk at 30 days of 4.3% for any stroke or death, and 1.4% for disabling stroke or death.4 extrapolating this to uk data suggests that an excess of 261 patients will have a stroke or will die because of surgery for the benefit of 1070 patients saved from an ipsilateral stroke at five years.
PubMedID- 26530114 For ischemic stroke or tia with acute myocardial infarction complicated by left ventricular mural thrombus formation identified by echocardiography or other cardiac imaging techniques, for at least how long should the patients be treated with oral anticoagulation?
PubMedID- 25258633 Conclusion: this study showed decreased arterial stiffness indexes in ami patient's participated cr, with a significant relationship between the electromechanical properties of the la that may raise a question of the preventive effect of cr from atrial fibrillation and stroke in patients with acute myocardial infarction.
PubMedID- 25478506 Besides these, cardiogenic stroke (21), prognosis in patients with acute myocardial infarctions (21) and cardiovascular diseases (22) and recurrence of af after pulmonary venous isolation (23) have been reported to be predictable from la strain (either determined by tissue doppler imaging or 2d ste).
PubMedID- 25813797 This article reviews this new class of antiplatelet therapy in detail with an acute focus on the tracer (thrombin receptor antagonist for clinical event reduction in acute coronary syndrome) and tra 2 degrees p-timi 50 (trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction 50) trials.
PubMedID- 23129490 When rivaroxaban was compared with dabigatran 110 mg twice daily, the latter had lower efficacy for the prevention of disabling/fatal stroke and was associated with more myocardial infarction events.
PubMedID- 20655037 Present analyses examined whether there was an increased risk of myocardial infarction associated with non-warfarin anticoagulants (stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation iii and iv, re-ly, amadeus) or "anticoagulant equivalents" (atrial fibrillation clopidogrel trial with irbesartan for the prevention of vascular events) in patients with atrial fibrillation who are prescribed anticoagulation for stroke thromboprophylaxis.
PubMedID- 25465416 Methods: tra 2 degrees p-timi 50 (trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction 50) was a multinational, randomized, double-blind, placebo-controlled trial of vorapaxar in stable patients with prior myocardial infarction, peripheral arterial disease, or stroke.
PubMedID- 26511368 Authors' conclusions: ppar-gamma agonists appear to reduce recurrent stroke and total events of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and improve insulin sensitivity and the stabilisation of carotid plaques.
PubMedID- 25465417 Methods: the tra 2 degrees p-timi 50 (trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction 50) was a randomized, double-blind, placebo-controlled trial of vorapaxar 2.5 mg daily in 26,449 patients with atherosclerosis, stratified by qualifying disease (mi, pad, or cvd).
PubMedID- 22837916 Other diabetes complications such as cerebral stroke, signs of neuropathy, myocardial infarction/cardiac bypass/angioplasty, and end-stage renal failure requiring dialysis or transplant were determined.
PubMedID- 23559938 major periodontal pathogens like aggregatibacter actinomycetemcomitans and porphyromonas gingivalis have shown clear associations with future stroke, increased risk of myocardial infarction, and acute coronary syndrome.
PubMedID- 21198447 Outcome events were fatal or non-fatal stroke and the composite of stroke, myocardial infarction, or vascular death (major vascular events).
PubMedID- 24399670 Authors' conclusions: ppar-gamma agonists were demonstrated to reduce recurrent stroke and total events of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and improve insulin sensitivity and the stabilisation of carotid plaques.
PubMedID- 25692111 Acute stroke with concomitant acute myocardial infarction: will you thrombolyse.
PubMedID- 22627990 Inclusion of stroke with myocardial infarction and sudden death among the outcome cluster of cardiovascular events in risk prediction instruments, moreover, is appropriate because of the impact of stroke on morbidity and mortality, the similarity of many approaches to prevention of stroke and these other forms of vascular disease, and the importance of stroke relative to coronary disease in some subpopulations.
PubMedID- 22622073 One patient with symptomatic carotid occlusion without recurrent stroke died due to myocardial infarction 6 months after surgery.
PubMedID- 21196058 However, the association between ses and stroke incidence in patients with acute myocardial infarction (ami) has not been studied.
PubMedID- 23782919 Similar risk factors predispose patients to ischemic stroke as that of myocardial infarction.

Page: 1